Industrie moet meer doen voor beschikbaar houden werkzame antibiotica
Rinke van den Brink of NOS reports on the Antimicrobial Resistance Benchmark and how companies should do more to ensure the effective antibiotics remain available to patients.
Date
23 January 2018
This article covers the actions pharmaceutical companies must take to ensure that effective antibiotics remain available to patients. It also states that companies must develop new antibiotics and better control where antibiotic resistance arises.